Published in Proc Natl Acad Sci U S A on October 10, 1995
Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. EMBO J (1998) 1.03
Conformational variation in structures of classical and non-classical MHCII proteins and functional implications. Immunol Rev (2012) 1.00
Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc Natl Acad Sci U S A (1995) 0.98
Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. Proc Natl Acad Sci U S A (1997) 0.94
An Analysis of MIF Structural Features that Control Functional Activation of CD74. Chem Biol (2015) 0.86
An asymmetric deuterium labeling strategy to identify interprotomer and intraprotomer NOEs in oligomeric proteins. J Biomol NMR (1998) 0.84
Stoichiometry of HLA class II-invariant chain oligomers. PLoS One (2011) 0.84
HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange. Front Immunol (2013) 0.77
A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells. F1000Res (2016) 0.76
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74. Cytokine (2016) 0.75
Invariant Chain Complexes and Clusters as Platforms for MIF Signaling. Cells (2017) 0.75
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science (1992) 7.00
Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol (1994) 4.29
Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (1990) 3.54
HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (1992) 2.54
Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci U S A (1991) 2.25
Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature (1991) 2.14
Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature (1990) 2.11
Characterization of a functionally important mobile domain of GroES. Nature (1993) 1.74
The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J Exp Med (1994) 1.67
Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature (1993) 1.67
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science (1992) 1.63
In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity (1994) 1.59
Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J Cell Biol (1990) 1.49
Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. J Immunol (1993) 1.41
Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J Exp Med (1995) 1.37
Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J Exp Med (1995) 1.37
Mobility of polypeptide chain in the pyruvate dehydrogenase complex revealed by proton NMR. Nature (1981) 1.35
Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J Exp Med (1994) 1.32
The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci U S A (1993) 1.32
MHC class II antigen processing: biology of invariant chain. Curr Opin Immunol (1994) 1.26
Dynamics of the multidomain fibrinolytic protein urokinase from two-dimensional NMR. Nature (1989) 1.04
Invariant chain associates with HLA class II antigens via its extracytoplasmic region. J Immunol (1986) 1.03
A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J Exp Med (1994) 1.02
Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern. Mol Immunol (1994) 0.86
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (1987) 12.43
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (1993) 8.75
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (1994) 7.13
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 6.20
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (1988) 5.99
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A (2001) 5.92
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A (1992) 5.02
Identification of self peptides bound to purified HLA-B27. Nature (1991) 4.88
Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell (1985) 4.84
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell (2001) 4.44
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol (1991) 4.44
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A (1984) 4.37
Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature (1989) 4.34
Coiled coils in both intracellular vesicle and viral membrane fusion. Cell (1998) 4.26
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature (1991) 3.84
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature (1992) 3.82
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat Struct Biol (1999) 3.72
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature (1994) 3.60
The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell (1993) 3.44
Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol (1983) 3.43
The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell (1992) 3.27
Structural basis for membrane fusion by enveloped viruses. Mol Membr Biol (1999) 3.26
Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature (1992) 3.12
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry (1992) 3.03
The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (1995) 2.90
Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity (1999) 2.86
The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell (1992) 2.79
Different clinical features of aortic intramural hematoma versus dissection involving the ascending aorta. J Am Coll Cardiol (2001) 2.77
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation (2001) 2.77
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology (1989) 2.74
Refinement of the influenza virus hemagglutinin by simulated annealing. J Mol Biol (1990) 2.61
Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol (2001) 2.52
Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology (1997) 2.51
Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell (1992) 2.47
Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli. J Mol Biol (1982) 2.46
Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J (1990) 2.42
Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature (1998) 2.41
Crystallographic determination of symmetry of aspartate transcarbamylase. Nature (1968) 2.37
Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol (2001) 2.34
Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity (1998) 2.31
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A (1995) 2.24
Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. Biochemistry (1989) 2.24
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science (1994) 2.24
Aerobic-anaerobic gene regulation in Escherichia coli: control by the ArcAB and Fnr regulons. Res Microbiol (1995) 2.21
The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J (1996) 2.21
Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol (1988) 2.21
Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology (1986) 2.13
X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity (1997) 2.07
alpha beta T cell receptor ligand-specific oligomerization revisited. Immunity (2001) 2.04
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A (2001) 2.04
Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J (2000) 2.00
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J Virol (1995) 1.96
Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology (1998) 1.95
Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med (1998) 1.94
Evidence from studies with a cross-linking reagent that the haemagglutinin of influenza virus is a trimer. Virology (1977) 1.93
Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. J Biol Chem (1985) 1.91
Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing. EMBO J (2001) 1.91
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci U S A (1983) 1.88
Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology (2000) 1.87
Side-branch occlusion after rotational atherectomy of in-stent restenosis: incidence, predictors, and clinical significance. Catheter Cardiovasc Interv (2000) 1.82
Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer. Nat Struct Biol (1998) 1.82
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A (1991) 1.79
Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature (1994) 1.79
Studies of influenza haemagglutinin-mediated membrane fusion. Virology (1986) 1.78
A structural motif in the variant surface glycoproteins of Trypanosoma brucei. Nature (1993) 1.77
Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J Immunol (2001) 1.77
Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell (1988) 1.77
Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J (1995) 1.74
The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site. J Immunol (2000) 1.74
Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin. Nature (1984) 1.72
Antigenic peptide binding by class I and class II histocompatibility proteins. Structure (1994) 1.71
Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol (1987) 1.70
Membrane fusion by peptide analogues of influenza virus haemagglutinin. J Gen Virol (1988) 1.69
Integration of simple sequence repeat (SSR) markers into a molecular linkage map of common bean (Phaseolus vulgaris L.). J Hered (2001) 1.69
Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J Virol (1986) 1.65
Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. Virology (1984) 1.64
Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol (2000) 1.62
Genetic analysis of transcriptional activation and repression in the Tn21 mer operon. J Bacteriol (1989) 1.62
Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation (2001) 1.61
A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant (2011) 1.60
Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci U S A (2001) 1.60
Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J Immunol (1996) 1.59